A Novel Mechanism of Restriction by an APOBEC3 Protein
APOBEC3 蛋白的新限制机制
基本信息
- 批准号:8780591
- 负责人:
- 金额:$ 18.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-01 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:Alu ElementsAmino Acid SubstitutionAmino AcidsAnti-Retroviral AgentsAntiviral AgentsApolipoproteinsCD4 Positive T LymphocytesCellsCercopithecidaeChimeric ProteinsColobus GenusCysteineCytidine DeaminaseDNADNA DamageDNA VirusesDNA biosynthesisDataDeaminaseDeaminationElementsEpithelial CellsFamilyFutureGenesGenomeGlutamatesGoalsHIVHIV-1Hela CellsHistidineHominidaeHumanHuman ActivitiesHuman PapillomavirusHuman T-Cell Leukemia VirusesImmunityInfectionInterferonsLymphocyteMacacaMacaca mulattaMessenger RNAMice Minute VirusMolecularParvovirusPhasePlayPositioning AttributePrimatesProductionPropertyProtein FamilyProtein InhibitionProteinsProtonsRNA BindingReportingResearch PersonnelRetroelementsRetrotranspositionRetrotransposonReverse TranscriptionRoleSIVSubfamily lentivirinaeTertiary Protein StructureTranscriptViralViral GenomeViral PhysiologyViral ProteinsVirusVirus ReplicationZincbasecofactordesignguerezainhibitor/antagonistinnovationinsertion/deletion mutationinsightmacrophagemembermonocytemutantnonhuman primatenovelpolypeptidepreventpublic health relevanceresponsesimian human immunodeficiency virustat Protein
项目摘要
DESCRIPTION (provided by applicant): The lentiviruses all encode for a Vif protein that has been shown to interact with members of the apolipoprotein mRNA-editing, catalytic polypeptide-like 3 (APOBEC3) superfamily of proteins. The APOBEC3 proteins are cytidine deaminases that are thought to play an important role in innate anti-viral immunity. Humans and macaques both encode for seven APOBEC3 genes (A3A, A3B, A3C, A3D, A3F, A3G, and A3H). The APOBEC3 proteins can be broadly divided into the single deaminase domain (A3A, A3C, and A3H) and double deaminase domain proteins (A3B, A3D, A3F, and A3G). Human A3A (hA3A) does not restrict the replication of HIV-1 vif in 293 cells or HeLa cells but has recently been shown to inhibit replication of HIV vif in macrophage-derived macrophages (MDM). In contrast, rhA3A from rhesus macaques is capable of restricting both HIV-1 and SHIV (expressing the SIV Vif). We recently have assessed the ability of other non-human primate A3A proteins to restrict HIV-1 and HIV-1 vif. We present preliminary data that the A3A protein from the Old World monkey, Colobus guereza (the mantled guereza, colA3A), not only inhibits the replication of HIV-1 and HIV-1 vif but also inhibits virus production in producer cells. Our preliminary studies indicate that the colA3A inhibits by a novel post-entry mechanism and, but not after, proviral integration. In Specific Aim 1, we propose to determine the mechanism though which colA3A inhibits HIV-1 replication and assess the molecular determinants involved. In Specific Aim 2, we propose to determine whether expression of colA3A in human CD4+ T cells and macrophages can restrict HIV-1 in cells it naturally infects. The proposed studies will provide mechanistic insight into this novel mechanism of A3 protein inhibition of HIV-1, which could serve as a new anti-viral strategy against HIV-1.
描述(由申请人提供):慢病毒均编码Vif蛋白,已显示Vif蛋白与载脂蛋白mRNA编辑、催化多肽样3(APOBEC 3)蛋白超家族成员相互作用。APOBEC 3蛋白是胞苷脱氨酶,被认为在先天性抗病毒免疫中起重要作用。人类和猕猴都编码7个APOBEC 3基因(A3 A,A3 B,A3 C,A3 D,A3 F,A3 G和A3 H)。APOBEC 3蛋白质可大致分为单脱氨酶结构域(A3 A、A3 C和A3 H)和双脱氨酶结构域蛋白质(A3 B、A3 D、A3 F和A3 G)。人A3 A(hA 3A)不限制HIV-1 vif在293细胞或HeLa细胞中的复制,但最近已显示出抑制HIV vif在巨噬细胞衍生的巨噬细胞(MDM)中的复制。相反,来自恒河猴的rhA 3A能够限制HIV-1和SHIV(表达SIV Vif)。我们最近评估了其他非人灵长类动物A3 A蛋白限制HIV-1和HIV-1 vif的能力。我们目前的初步数据表明,A3 A蛋白从旧大陆猴,疣猴(mantled guereza,colA 3A),不仅抑制HIV-1和HIV-1病毒的复制,但也抑制生产细胞中的病毒生产。我们的初步研究表明,colA 3A抑制一种新的后进入机制,但不是后,前病毒整合。在具体目标1中,我们建议确定colA 3A抑制HIV-1复制的机制,并评估所涉及的分子决定因素。在具体目标2中,我们建议确定colA 3A在人CD 4 + T细胞和巨噬细胞中的表达是否可以限制HIV-1在其自然感染的细胞中的表达。这些研究将为A3蛋白抑制HIV-1的新机制提供机制上的见解,这可能成为一种新的抗HIV-1的抗病毒策略。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.
- DOI:10.1016/j.virol.2016.08.001
- 发表时间:2016-11
- 期刊:
- 影响因子:3.7
- 作者:Yaqiong Wang;Zekun Wang;A. Pramanik;M. Santiago;J. Qiu;E. Stephens
- 通讯作者:Yaqiong Wang;Zekun Wang;A. Pramanik;M. Santiago;J. Qiu;E. Stephens
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward Brice Stephens其他文献
Edward Brice Stephens的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward Brice Stephens', 18)}}的其他基金
The role of APOBEC3 proteins in innate immune responses in developing thymocytes
APOBEC3 蛋白在胸腺细胞发育中先天免疫反应中的作用
- 批准号:
9065291 - 财政年份:2016
- 资助金额:
$ 18.88万 - 项目类别:
A Novel Mechanism of Restriction by an APOBEC3 Protein
APOBEC3 蛋白的新限制机制
- 批准号:
8658651 - 财政年份:2013
- 资助金额:
$ 18.88万 - 项目类别:
Role of Targeted Mutations in ViF on SHIV Pathogenesis
ViF 靶向突变在 SHIV 发病机制中的作用
- 批准号:
7026384 - 财政年份:2005
- 资助金额:
$ 18.88万 - 项目类别:
Role of Targeted Mutations in ViF on SHIV Pathogenesis
ViF 靶向突变在 SHIV 发病机制中的作用
- 批准号:
6947546 - 财政年份:2005
- 资助金额:
$ 18.88万 - 项目类别:
A New DNA Vaccine Against HIV Disease in Macaques
一种针对猕猴 HIV 疾病的新型 DNA 疫苗
- 批准号:
7242607 - 财政年份:2004
- 资助金额:
$ 18.88万 - 项目类别:
A New DNA Vaccine Against HIV Disease in Macaques
一种针对猕猴 HIV 疾病的新型 DNA 疫苗
- 批准号:
7433286 - 财政年份:2004
- 资助金额:
$ 18.88万 - 项目类别:
相似海外基金
Phenotypic consequences of a modern human-specific amino acid substitution in ADSL
ADSL 中现代人类特异性氨基酸取代的表型后果
- 批准号:
24K18167 - 财政年份:2024
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Estimation of stability and functional changes due to amino acid substitution using molecular simulations
使用分子模拟估计氨基酸取代引起的稳定性和功能变化
- 批准号:
20H03230 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanisms of prion protein conversion caused by an amino acid substitution in glycosylphosphatidylinositol anchoring signal peptide
阐明糖基磷脂酰肌醇锚定信号肽中氨基酸取代引起的朊病毒蛋白转化机制
- 批准号:
16K18790 - 财政年份:2016
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Amino acid substitution without genetic modification
无需基因改造的氨基酸替代
- 批准号:
15H05491 - 财政年份:2015
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Study on PSII hydrogen bond networks by exhaustive amino acid substitution
穷举氨基酸取代研究PSII氢键网络
- 批准号:
15K07110 - 财政年份:2015
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the effect of HCV propagationa and IFN sensitivity by amino acid substitution in interferon sensitivity-determining region.
阐明干扰素敏感性决定区氨基酸取代对 HCV 传播和干扰素敏感性的影响。
- 批准号:
26860309 - 财政年份:2014
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The analysis of the restriction of amino acid substitution on the hemagglutinin molecule of influenza A virus
甲型流感病毒血凝素分子氨基酸取代限制性分析
- 批准号:
14370104 - 财政年份:2002
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Changes in the Substrate Specificities of Farnesyl Diphosphate Synthase by a Single Amino Acid Substitution
单一氨基酸取代对法尼基二磷酸合酶底物特异性的变化
- 批准号:
12680587 - 财政年份:2000
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses of the Relationship between Amino Acid Substitution and Phenotype of the Tail Sheath Protein of Bacteriophage T4
噬菌体T4尾鞘蛋白氨基酸取代与表型关系分析
- 批准号:
02680125 - 财政年份:1990
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Hypothesis: Both appearance and disappearance of viruses are controlled by the accumulation of amino acid substitution in receptor binding domain
假设:病毒的出现和消失都是由受体结合域氨基酸取代的积累控制的
- 批准号:
02454184 - 财政年份:1990
- 资助金额:
$ 18.88万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)














{{item.name}}会员




